CYAD
Celyad Oncology SA American Depositary Shares
CYAD
CYAD
Delisted
CYAD was delisted on the 18th of May, 2023.
12 hedge funds and large institutions have $19.3M invested in Celyad Oncology SA American Depositary Shares in 2018 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
12
Holders Change
–
Holders Change %
0%
% of All Funds
0.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
5
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
Millennium Management
New York
|
+$913K |
2 |
Victory Capital Management
San Antonio,
Texas
|
+$452K |
3 |
Wells Fargo
San Francisco,
California
|
+$147K |
4 |
Morgan Stanley
New York
|
+$43.5K |
5 |
SLG
Stanley-Laman Group
Berwyn,
Pennsylvania
|
+$32.5K |
Top Sellers
1 |
EP
Eversept Partners
New York
|
-$382K |
2 |
Renaissance Technologies
New York
|
-$205K |
3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$7.31K |
4 |
UBS Group
Zurich,
Switzerland
|
-$158 |